Home Newsfeeds Credit Suisse Downgrades PACCAR to Neutral, Lowers Price Target to $105

Credit Suisse Downgrades PACCAR to Neutral, Lowers Price Target to $105

Credit Suisse analyst Jamie Cook downgrades PACCAR (NASDAQ:PCAR) from Outperform to Neutral and lowers the price target from $107 to $105.

byBenzinga Newsdesk

January 12, 2023

1 minute read

Credit Suisse analyst Jamie Cook downgrades PACCAR (NASDAQ:PCAR) from Outperform to Neutral and lowers the price target from $107 to $105.

Telsey Advisory Group Reiterates Outperform on Honest Co, Maintains $6 Price Target

By Benzinga Newsdesk

March 13, 5:38 AM

Telsey Advisory Group analyst Dana Telsey reiterates Honest Co (NASDAQ:HNST) with a Outperform and maintains $6 price target.

HNST

Legal
News

U.S. Department Of Labor Krispy Kreme To Pay More Than $1.1M To 516 Workers After U.S. Department Of Labor Finds Systemic Overtime Violations

By Benzinga Newsdesk

November 17, 1:35 PM

https://www.dol.gov/newsroom/releases/whd/whd20221117

DNUT

Reliance Industries Enters Into Agreement To Invest Alongside Digital Realty And Brookfield Infrastructure To Expand Data Center Joint Venture In India

By Happy Mohamed

July 24, 4:16 PM

'Digital Connexion: A Brookfield, Jio and Digital Realty Company' to develop critical digital infrastructure to meet rapidly-growing global and local customer demand in Indian market AUSTIN, Texas, July 24,

DLR

Analyst Ratings

5 Analysts Have This to Say About Rocket Pharmaceuticals

By Benzinga Insights

April 19, 11:00 AM

Over the past 3 months, 5 analysts have published their opinion on Rocket Pharmaceuticals (NASDAQ:RCKT) stock. These analysts…

RCKT

Credit Suisse Downgrades PACCAR to Neutral, Lowers Price Target to $105

Related Posts

Telsey Advisory Group Reiterates Outperform on Honest Co, Maintains $6 Price Target

U.S. Department Of Labor Krispy Kreme To Pay More Than $1.1M To 516 Workers After U.S. Department Of Labor Finds Systemic Overtime Violations

Reliance Industries Enters Into Agreement To Invest Alongside Digital Realty And Brookfield Infrastructure To Expand Data Center Joint Venture In India

5 Analysts Have This to Say About Rocket Pharmaceuticals